ReviewJournal of nephrology2022

Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D.

Mario Cozzolino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.